Ziconotide via spine pump for chronic non-cancer pain
Treatments studied
Part of Pain clinical trials.
This study looks at a medicine called ziconotide, given through a pump in your spine (intrathecal delivery) to treat chronic pain that is not from cancer. It aims to learn how safe and effective this treatment is in real-world patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have chronic pain that is not caused by cancer, and it needs advanced treatments like a spine pump
- For the first group: you are already receiving ziconotide through a spine pump
- For the second group: you have never had a spine pump, or you have one but are not getting ziconotide yet, and your doctor is planning to add it
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with severe, long-lasting pain that has not responded to other treatments, to see how the pain medicine ziconotide works in everyday clinical practice. You may be considered if you’re being evaluated for an implanted pain-delivery system that gives ziconotide into the spinal fluid.
This study tests a drug called ziconotide, given through a pump that delivers it directly into the fluid around your spinal cord, to see if it can help with nerve pain caused by chemotherapy. The drug is already approved for severe chronic pain, but this research focuses on chemotherapy-related nerve pain.
This study tests a new way to manage severe pain linked to pancreatic cancer when standard pain medicine isn't working or causes side effects. It aims to see if this treatment can safely reduce pain and improve quality of life.
This study compares two treatments for long-term back pain after surgery: a spinal cord stimulator (a device that sends mild electrical pulses to your spine) and a pump that delivers pain medicine directly to your spinal fluid. It will look at which treatment you prefer and how well it works over time.
This study tests an experimental drug called ITX24-01 for people with severe, long-term neck or lower back pain that comes from the small joints in the spine. If you're already planning to have a procedure called radiofrequency ablation (RFA) to treat this pain, this trial may help you by testing if the drug can improve your pain relief.
This study follows people receiving Inceptiv, a spinal cord stimulator from Medtronic, to see how well it works over time. It is for adults with chronic back or limb pain who have not tried spinal cord stimulation before.
Hear when a new Pain, Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.